Lesaka Technologies
LSAK · NASDAQ
About LSAK
- Employees
- 3,728
- Headquarters
- Johannesburg, Gauteng
- Listed
- Aug 3, 2005
- Sector
- Financials
- Industry
- Financial Services
- Website
- lesakatech.com
LSAK key statistics
- Market cap
- 349.18M
- Price-earnings ratio
- 140.00
- Dividend yield
- —
- Average volume
- 236.60K
- Volume
- 107.31K
- Open price
- $4.20
- High today
- $4.30
- Low today
- $4.07
- 52 Week high
- $5.54
- 52 Week low
- $3.62
Lesaka Technologies (LSAK) at a glance
Lesaka Technologies (LSAK) last traded at $4.07, with a market cap of 349.18M and a price-to-earnings ratio of 140.00.
Today the stock has traded between $4.07 and $4.30. The current price is 0.0% above the day's low and 5.2% below its high.
Volume so far is 107.31K shares, below the average of 236.60K shares a day.
Over the past year Lesaka Technologies has ranged from $3.62 to $5.54, and now sits 23% of the way up that range.
Lesaka Technologies met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q4 FY26 it reported $0.15 per share against an estimate of $0.0918.
LSAK earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 443.3% on average.
- Q1 FY25: reported -$0.07 per share against an estimate of -$0.0408
- Q2 FY25: reported $0.02 per share against an estimate of -$0.0612
- Q3 FY25: reported -$0.02 per share against an estimate of $0.0204
- Q4 FY25: reported -$0.05 per share against an estimate of $0.0408
- Q1 FY26: reported $0.11 per share against an estimate of $0.0102
- Q3 FY26: reported $0.11 per share against an estimate of $0.0102
- Q2 FY26: reported $0.15 per share against an estimate of $0.0918
- Q4 FY26: reported $0.15 per share against an estimate of $0.0918
LSAK news
- Press releaseGlobe Newswire
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
- Press releaseGlobe Newswire
LESAKA (LSAK) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C Continues Investigation into Lesaka Technologies, Inc. on Behalf of Lesaka Stockholders and Encourages Investors to Contact the Firm
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lesaka Technologies, Inc. - LSAK
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.